BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31698021)

  • 1. Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability.
    Zhan Y; Raza MU; Yuan L; Zhu MY
    Neuroscience; 2019 Dec; 422():184-201. PubMed ID: 31698021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
    Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss.
    Iravani MM; Sadeghian M; Rose S; Jenner P
    J Neural Transm (Vienna); 2014 Dec; 121(12):1493-505. PubMed ID: 24781752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenaline is crucial for the substantia nigra dopaminergic cell maintenance.
    Af Bjerkén S; Stenmark Persson R; Barkander A; Karalija N; Pelegrina-Hidalgo N; Gerhardt GA; Virel A; Strömberg I
    Neurochem Int; 2019 Dec; 131():104551. PubMed ID: 31542295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesioning noradrenergic neurons of the locus coeruleus in C57Bl/6 mice with unilateral 6-hydroxydopamine injection, to assess molecular, electrophysiological and biochemical changes in noradrenergic signaling.
    Szot P; Knight L; Franklin A; Sikkema C; Foster S; Wilkinson CW; White SS; Raskind MA
    Neuroscience; 2012 Aug; 216():143-57. PubMed ID: 22542679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vulnerability to a Metabolic Challenge Following Perinatal Asphyxia Evaluated by Organotypic Cultures: Neonatal Nicotinamide Treatment.
    Perez-Lobos R; Lespay-Rebolledo C; Tapia-Bustos A; Palacios E; Vío V; Bustamante D; Morales P; Herrera-Marschitz M
    Neurotox Res; 2017 Oct; 32(3):426-443. PubMed ID: 28631256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic lesions of the noradrenergic system trigger induction of oxidative stress and inflammation in the ventral midbrain.
    Barut J; Rafa-Zabłocka K; Jurga AM; Bagińska M; Nalepa I; Parlato R; Kreiner G
    Neurochem Int; 2022 May; 155():105302. PubMed ID: 35150790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.
    McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P
    Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism.
    Kreiner G; Rafa-Zabłocka K; Barut J; Chmielarz P; Kot M; Bagińska M; Parlato R; Daniel WA; Nalepa I
    Sci Rep; 2019 Mar; 9(1):5262. PubMed ID: 30918302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective Effects of Intranasal IGF-1 against Neonatal Lipopolysaccharide-Induced Neurobehavioral Deficits and Neuronal Inflammation in the Substantia Nigra and Locus Coeruleus of Juvenile Rats.
    Tien LT; Lee YJ; Pang Y; Lu S; Lee JW; Tseng CH; Bhatt AJ; Savich RD; Fan LW
    Dev Neurosci; 2017; 39(6):443-459. PubMed ID: 28787734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
    German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK
    Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.
    Fonseca CP; Gama S; Saavedra A; Baltazar G
    Biochim Biophys Acta; 2014 Jul; 1842(7):927-34. PubMed ID: 24632468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxin-induced DNA damage is persistent in SH-SY5Y cells and LC neurons.
    Wang Y; Musich PR; Cui K; Zou Y; Zhu MY
    Neurotox Res; 2015 May; 27(4):368-83. PubMed ID: 25724887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical lower sensitivity of Locus Coeruleus than Substantia Nigra pars compacta neurons to acute actions of rotenone.
    Yee AG; Freestone PS; Bai JZ; Lipski J
    Exp Neurol; 2017 Jan; 287(Pt 1):34-43. PubMed ID: 27771354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive analysis of the effect of DSP4 on the locus coeruleus noradrenergic system in the rat.
    Szot P; Miguelez C; White SS; Franklin A; Sikkema C; Wilkinson CW; Ugedo L; Raskind MA
    Neuroscience; 2010 Mar; 166(1):279-91. PubMed ID: 20045445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.
    Taylor TN; Alter SP; Wang M; Goldstein DS; Miller GW
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):97-105. PubMed ID: 24025942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ; Groover O; Smith Y
    Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.